AIIMS on the verge to recognise the Dengue sub-type in Delhi
Advertisement
Even as the Health Ministry and medical experts continue to be alarmed with the rise in number of dengue cases being reported in Delhi (currently at 831); the process of identifying the sub-type of the Delhi-related dengue cases is underway at the All India Institute of Medical Sciences (AIIMS).
The results, which are expected to come in a week’s time, will help identify the subtype of dengue-types I and III are mild causing classic dengue fever and fever without shock, respectively, dengue types II and IV are considered deadly. These cause fever, bleeding and a drop in platelet count, as reported by Times of India.
"All four serotypes (1, 2, 3 and 4) of dengue were isolated from time to time in various states. The report of the serotypes circulating in Delhi is expected within a week," an official statement quoting Union health secretary B P Sharma said.
The results, which are expected to come in a week’s time, will help identify the subtype of dengue-types I and III are mild causing classic dengue fever and fever without shock, respectively, dengue types II and IV are considered deadly. These cause fever, bleeding and a drop in platelet count, as reported by Times of India.
"All four serotypes (1, 2, 3 and 4) of dengue were isolated from time to time in various states. The report of the serotypes circulating in Delhi is expected within a week," an official statement quoting Union health secretary B P Sharma said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.